-
Mashup Score: 100Finerenone and Kidney Outcomes in Patients with Heart Failure: The FINEARTS-HF Trial: - 1 month(s) ago
AbstractBackgroundFinerenone has kidney protective effects in patients with chronic kidney disease (CKD) with type 2 diabetes, but effects on kidney outcomes in patients with heart failure (HF) wit…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 23Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM - 1 month(s) ago
Establishing cardiovascular safety of new therapies for type 2 diabetes is important. Safety data are available for the subcutaneous form of the glucagon-like peptide-1 receptor agonist semaglutide…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…
-
-
Mashup Score: 23Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes | NEJM - 1 month(s) ago
Establishing cardiovascular safety of new therapies for type 2 diabetes is important. Safety data are available for the subcutaneous form of the glucagon-like peptide-1 receptor agonist semaglutide…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
RT @DanielJDrucker: As a reminder, PIONEER 6 also demonstrated the cardiovascular safety of oral semaglutide https://t.co/Ix6iFDmq5P As lo…
-
-
Mashup Score: 5
Dronedarone for the treatment of atrial fibrillation with concomitant heart failure with preserved and mildly reduced ejection fraction: a post-hoc analysis of the ATHENA trial.
Source: onlinelibrary.wiley.comCategories: General Medicine News, CardiologistsTweet-
@kaulcsmc @hvanspall @djc795 @gcfmd @AHA_Research @JonPicciniSr @DCRINews Unclear—no dedicated HFpEF RCT has been conducted. Perhaps extrapolation from P3 #ATHENA (largest RCT of an AAD) where such pts were somewhat represented We looked at that HFpEF subset in post hoc & appeared favorable, but glad to see new RCTs underway! https://t.co/ujc8zIU85W
-
-
Mashup Score: 6Effect of finerenone on the KCCQ in patients with HFmrEF/HFpEF: A prespecified analysis of FINEARTS-HF: - 1 month(s) ago
ABSTRACTBackgroundPatients with heart failure (HF) are limited by symptoms and have impaired quality of life. The Kansas City Cardiomyopathy Questionnaire (KCCQ) is a patient-reported outcome measu…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
Three #SimPub with #HFSA2024 in @JACCJournals from #FINEARTSHF KCCQ https://t.co/o8w1T123uR Recent Worsening HF https://t.co/Xrjoo2Cyry Time to Clinical Benefit https://t.co/4EW33xTXFX https://t.co/0fflWyebsD
-
-
Mashup Score: 2Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes - 2 month(s) ago
Nature Medicine – This participant-level pooled analysis of the three phase 3 trials that have tested the non-steroidal mineralocorticoid receptor antagonist finerenone in patients with heart…
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet-
RT @NephJC: The link to the @NatureMedicine article itself! Do not forget to take a look before we start #NephJC https://t.co/2mYfefr9mP
-
-
Mashup Score: 2Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomes - 2 month(s) ago
Nature Medicine – This participant-level pooled analysis of the three phase 3 trials that have tested the non-steroidal mineralocorticoid receptor antagonist finerenone in patients with heart…
Source: www.nature.comCategories: General Medicine News, CardiologistsTweet-
RT @NephJC: The link to the @NatureMedicine article itself! Do not forget to take a look before we start #NephJC https://t.co/2mYfefr9mP
-
-
Mashup Score: 26
Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA University of Glasgow, Glasgow, Scotland, United Kingdom National Heart Centre Singapore and Duke-National University of Singapore, Singapore University of Milano-Bicocca, Papa Giovanni XXIII Hospital, Bergamo, Italy Northwestern University Feinberg School of
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
RT @drbennisahmed: Time to Significant Benefit of Finerenone in Patients With Heart Failure https://t.co/Fy7fDygLGC https://t.co/3ZqCJc2goR
-
-
Mashup Score: 50A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart Failure | NEJM - 2 month(s) ago
Actions of angiotensin II may contribute to the progression of heart failure despite treatment with currently recommended drugs. We therefore evaluated the long-term effects of the addition of the …
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
Enalapril was the best studied RASi & was tested at doses *higher* than those proven to ↓ mortality in #CONSENSUS & #SOLVD Valsartan was never proven to ↓ mortality & would have been considered a straw man comparator...perhaps by the very same people🙃 https://t.co/4z3CUOIBZS https://t.co/tjV6mFY23v https://t.co/31BsnnR95W
-
-
Mashup Score: 19In Memoriam: George L. Bakris, MD (1952 to 2024) | Hypertension - 3 month(s) ago
View all available purchase options and get full access to this article. Request permissions for this article. Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, Indianapolis, IN (R.A.). Department of Medicine, University of Maryland, Baltimore (M.R.W.). Correspondence to: Rajiv Agarwal, Department of Medicine, Division of Nephrology, Richard L. Roudebush VA Medical Center, 1481 West 10th St, 111N, Indianapolis, IN 46202, Email [email protected] If you have the
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
RT @AgarwalRajivMD: Matt Weir & I offer an obituary of our affable colleage George Bakris https://t.co/J7rSgdm2Fy "With a diagnosis of canc…
-
First #LBCT of #KidneyWk from #FINEARTSHF now #SimPub in @JACCJournals Finerenone does not affect traditional kidney composite endpoint or longterm eGFR slope …but w large, early, & clinically meaningful (30%) reduction in UACR & new-onset albuminuria https://t.co/TX6JmcDnz8 https://t.co/Tkya6teaxB